{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T21:04:48Z","timestamp":1771362288132,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","onlinecjc.ca","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.cjca.2015.05.020","type":"journal-article","created":{"date-parts":[[2015,6,6]],"date-time":"2015-06-06T15:19:33Z","timestamp":1433603973000},"page":"226-233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Effect of Baseline Thrombocytopenia on Ischemic Outcomes in Patients With Acute Coronary Syndromes Who Undergo Percutaneous Coronary Intervention"],"prefix":"10.1016","volume":"32","author":[{"given":"Mayank","family":"Yadav","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"G\u00e9n\u00e9reux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5400-9516","authenticated-orcid":false,"given":"Gennaro","family":"Giustino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahesh V.","family":"Madhavan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sorin J.","family":"Brener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Mintz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6287-5414","authenticated-orcid":false,"given":"Adriano","family":"Caixeta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roxana","family":"Mehran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregg W.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2015.05.020_bib1","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ahj.2010.10.035","article-title":"Incidence and clinical consequences of acquired thrombocytopenia after antithrombotic therapies in patients with acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial","volume":"161","author":"Caixeta","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2015.05.020_bib2","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1161\/CIRCULATIONAHA.108.827162","article-title":"Incidence and prognostic significance of thrombocytopenia developed during acute coronary syndrome in contemporary clinical practice","volume":"119","author":"Wang","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2015.05.020_bib3","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1161\/01.CIR.0000127867.41621.85","article-title":"Thrombocytopenia caused by abciximab or tirofiban and its association with clinical outcome in patients undergoing coronary stenting","volume":"109","author":"Merlini","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2015.05.020_bib4","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0735-1097(98)00252-6","article-title":"Occurrence and clinical significance of thrombocytopenia in a population undergoing high-risk percutaneous coronary revascularization. Evaluation of c7E3 for the Prevention of Ischemic Complications (EPIC) Study Group","volume":"32","author":"Berkowitz","year":"1998","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2015.05.020_bib5","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1161\/01.CIR.99.22.2892","article-title":"Clinical significance of thrombocytopenia during a non ST-elevation acute coronary syndrome: the Platelet Glycoprotein IIb\/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) trial experience","volume":"99","author":"McClure","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2015.05.020_bib6","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/01.CIR.103.5.643","article-title":"Prognostic significance of thrombocytopenia during hirudin and heparin therapy in acute coronary syndrome without ST elevation: Organization to Assess Strategies for Ischemic Syndromes (OASIS-2) study","volume":"103","author":"Eikelboom","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2015.05.020_bib7","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1067\/mhj.2000.106615","article-title":"Clinical correlates and course of thrombocytopenia during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb\/IIIa blockade","volume":"140","author":"Kereiakes","year":"2000","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2015.05.020_bib8","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1540-8183.2009.00424.x","article-title":"Occurrence, predictors, and outcomes of post-percutaneous coronary intervention thrombocytopenia in an unselected population","volume":"22","author":"Shenoy","year":"2009","journal-title":"J\u00a0Interv Cardiol"},{"key":"10.1016\/j.cjca.2015.05.020_bib9","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ahj.2008.02.003","article-title":"Thrombocytopenia at baseline is a predictor of inhospital mortality in patients undergoing percutaneous coronary intervention","volume":"156","author":"Overgaard","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2015.05.020_bib10","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ahj.2010.11.001","volume":"161","author":"Hakim","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2015.05.020_bib11","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1056\/NEJMoa0708191","article-title":"Bivalirudin during primary PCI in acute myocardial infarction","volume":"358","author":"Stone","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2015.05.020_bib12","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMoa062437","article-title":"Bivalirudin for patients with acute coronary syndromes","volume":"355","author":"Stone","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2015.05.020_bib13","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.ahj.2004.04.036","article-title":"Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale","volume":"148","author":"Stone","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2015.05.020_bib14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ahj.2008.02.008","article-title":"The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial: study design and rationale","volume":"156","author":"Mehran","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2015.05.020_bib15","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1056\/NEJMcpc049016","article-title":"Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Laboratory reference values","volume":"351","author":"Kratz","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2015.05.020_bib16","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2015.05.020_bib17","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3324\/haematol.2013.101949","article-title":"Abnormal platelet count is an independent predictor of mortality in the elderly and is influenced by ethnicity","volume":"99","author":"Msaouel","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.cjca.2015.05.020_bib18","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1161\/CIRCULATIONAHA.109.858316","article-title":"Adverse prognostic significance of thrombocytopenia in acute coronary syndrome: can anything be done about it?","volume":"119","author":"Warkentin","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2015.05.020_bib19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.7326\/M14-1589","article-title":"Platelet transfusion: a clinical practice guideline from the AABB","volume":"162","author":"Kaufman","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cjca.2015.05.020_bib20","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.cjca.2014.12.034","article-title":"Thrombocytopenia in acute coronary syndromes: etiologies and proposed management","volume":"31","author":"Sharma","year":"2015","journal-title":"Can J Cardiol"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X1500402X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X1500402X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T14:25:52Z","timestamp":1668695152000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X1500402X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0828282X1500402X"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2015.05.020","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Baseline Thrombocytopenia on Ischemic Outcomes in Patients With Acute Coronary Syndromes Who Undergo Percutaneous Coronary Intervention","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2015.05.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}